The miss in EPS estimates could negatively impact investor sentiment in the short term, but the beat on revenue forecasts and the year-over-year sales growth might offset this negative impact. Given the mixed results, the short-term impact on MCRI's stock price is likely to be neutral as investors weigh the earnings miss against the revenue beat.